Liver Disease News and Research

RSS

The liver is one of the largest solid organs of the body. It is located in the upper right part of the abdomen. Most of the organ lies under cover of the rib cage.

Pathway preferential estrogens may be a safer alternative to hormone replacement therapy, study shows

Postmenopausal women have increased risk of non-alcoholic fatty liver disease due to loss of estrogen from metabolic changes. A high-fat diet further exacerbates the disease, which can progress to cirrhosis and liver failure.

29 Oct 2021

Brown fat could be the key to healthy metabolism in obese people

Not all forms are obesity are the same and brown fat could make all the difference. A study led by Florian Kiefer's research group from the Division of Endocrinology and Metabolism of the Department of Medicine III at MedUni Vienna and Vienna General Hospital shows that people who are seriously overweight (obese) who also have active brown fat have a healthier metabolism and use more energy than obese people without brown fat.

29 Oct 2021

SARS-CoV-2 vaccination lowers risk of several outcomes after breakthrough infection

Researchers at the University of Oxford have conducted a study showing that vaccination against coronavirus disease 2019 (COVID-19) is associated with a lower risk of several sequelae among those who experience breakthrough infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Oct 2021

HCV treatment decreases protein activity levels involved in liver cirrhosis, research shows

Researchers at the Medical University of South Carolina report in the Journal of Viral Hepatitis that the activity levels of the proteins involved in liver scarring, or cirrhosis, begin to decrease immediately after treatment for the hepatitis C virus (HCV), suggesting the possibility of early healing.

26 Oct 2021

Safer, more effective therapies could help fight the obesity epidemic

Novel obesity treatments such as modulation of the gut microbiome and gene therapy are underutilized and could help fight the obesity epidemic, according to a new manuscript published in the Endocrine Society's journal, Endocrine Reviews.

26 Oct 2021

Researchers develop genetic risk score to predict development of alcohol-induced cirrhosis

An international research group led by the Centenary Institute has developed a world first genetic risk score (GRS) test able to identify patients at high-risk of developing alcohol-related cirrhosis.

26 Oct 2021

Novel Einstein-developed strategy successfully suppresses HIV infections in mice

Armed with a novel strategy they developed for bolstering the body's immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice-;offering a path to a functional cure for HIV and other chronic viral infections.

21 Oct 2021

Albert Einstein College of Medicine wins new NIH funding to support diabetes research

Albert Einstein College of Medicine has received a five-year, $4 million grant from the National Institutes of Health to support the New York Regional Center for Diabetes Translation Research (NY-CDTR).

20 Oct 2021

Washington University receives $7.5 million to support NIH's research on senescent cells

Washington University School of Medicine in St. Louis is joining the National Institutes of Health's new research network focused on the study of senescent cells, a rare and important population of cells that is difficult to study but vital for understanding aging and the diseases of aging, including cancer and neurodegeneration.

20 Oct 2021

Study may help investigate the role of gut virome in health and disease

A new study has added numerous previously uncharacterized viral genomes and genes to the ever-increasing worldwide pool of human gut viromes.

19 Oct 2021

UQ start-up secures $1.3 million seed investment to develop new treatment for liver disease

A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of $1.3 million from IP Group, a UK-based intellectual property business.

19 Oct 2021

Statin treatment and COVID-19 mortality

The authors highlight the importance of their study in clarifying and expanding the current understanding of the relationship between COVID-19 and statins.

18 Oct 2021

Contraceptive pill can reduce the risk of type 2 diabetes in women with PCOS, study reveals

A study led by the University of Birmingham has revealed for the first time that the contraceptive pill can reduce the risk of type 2 diabetes by over a quarter in women with polycystic ovary syndrome (PCOS).

15 Oct 2021

KHN’s ‘What the Health?’: The politics of vaccine mandates

Should covid vaccines be mandated? The answer to that question has become predictably partisan, as with almost everything else associated with the pandemic.

14 Oct 2021

Study identifies DNA mutations linking liver disease with obesity and diabetes

For the first time, DNA mutations in liver cells have been identified that impact metabolism and insulin sensitivity in patients with liver disease.

13 Oct 2021

New source of stem cells could help treat people with Alagille syndrome

Researchers from Sanford Burnham Prebys have discovered a new source of stem cells just outside the liver that could help treat people living with Alagille syndrome, a rare, incurable genetic disorder in which the bile ducts of the liver are absent, leading to severe liver damage and death.

12 Oct 2021

Liver Disease News and Research

Further Reading

Pathway preferential estrogens may be a safer alternative to hormone replacement therapy, study shows

Brown fat could be the key to healthy metabolism in obese people

SARS-CoV-2 vaccination lowers risk of several outcomes after breakthrough infection

HCV treatment decreases protein activity levels involved in liver cirrhosis, research shows

Safer, more effective therapies could help fight the obesity epidemic

Researchers develop genetic risk score to predict development of alcohol-induced cirrhosis

Novel Einstein-developed strategy successfully suppresses HIV infections in mice

Albert Einstein College of Medicine wins new NIH funding to support diabetes research

Washington University receives $7.5 million to support NIH's research on senescent cells

Study may help investigate the role of gut virome in health and disease

UQ start-up secures $1.3 million seed investment to develop new treatment for liver disease

Statin treatment and COVID-19 mortality

Contraceptive pill can reduce the risk of type 2 diabetes in women with PCOS, study reveals

KHN’s ‘What the Health?’: The politics of vaccine mandates

Study identifies DNA mutations linking liver disease with obesity and diabetes

New source of stem cells could help treat people with Alagille syndrome

6 months to live or die: How long should an alcoholic liver disease patient wait for a transplant?

Common oral diuretic pill may be a potential candidate for Alzheimer's treatment

Managing metabolic disease through time-restricted eating

New study to evaluate community-based approach to helping children manage asthma symptoms

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News